ENTITY

Tianjin Zhongxin Phrmctl Gp Cp (600329 CH)

5
Analysis
Health Care • China
Tianjin Zhongxin Pharmaceutical Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Group also manufactures gene-related biopharmaceutical products. Tianjin Zhongxin markets its products under the Great Wall, Cypress, and Health brand names.
more
•26 Jun 2025 17:00•Syndicated

1H 2025 Dividend Investing Update: Navigating the Yield Squeeze

Singapore's equity market is positioned to continue its resilient performance, with benchmark indices trending positively and dividend yields...

Logo
Syfe
15 Views
Share
•14 Jan 2024 16:11

Quiddity Leaderboard SSE50/180 Jun 24: US$1.3bn One-Way; Some New Names in the Expected Changes List

Collectively, the 5 expected changes for SSE 50 and the 18 expected changes for SSE 180 could generate US$1.3bn in one-way index flows.

Share
•25 Feb 2023 04:11

MSCI ACWI Uptrend Break; Defensives to Shine; Ideas in Staples, Health Care, Telecomm, Utilities

$93 on $ACWI has proven to be rock-solid resistance, and it now displays a 4.5-month uptrend violation signaling the pullback has officially begun....

Logo
492 Views
Share
•22 Mar 2021 00:00•Exchange-sponsored

Singapore Mid-Caps Edge Ahead of Regional Peers in YTD

Singapore’s current crop of 63 Mid-Cap stocks, with a market value between S$1 billion and S$5 billion, have averaged a 12% total return (6%...

Share
bullish•Gsh Corp Ltd
•21 Jan 2021 00:00•Exchange-sponsored

Growth Stocks Edge Higher with Value Stocks in Early 2021

Singapore stocks that recently ranked highly for Growth Factor Exposure have kept pace, and been marginally stronger than Value stock...

Share
x